Related references
Note: Only part of the references are listed.Current State of Type 1 Diabetes Treatment in the US: Updated Data From the T1D Exchange Clinic Registry
Kellee M. Miller et al.
DIABETES CARE (2015)
Development and validation of a cost-utility model for Type1 diabetes mellitus
S. Wolowacz et al.
DIABETIC MEDICINE (2015)
Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association
Sarah D. de Ferranti et al.
DIABETES CARE (2014)
Glycemic Control and Excess Mortality in Type 1 Diabetes
Marcus Lind et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus
Carl V. Asche et al.
PHARMACOECONOMICS (2014)
Validation of the IMS CORE Diabetes Model
Phil McEwan et al.
VALUE IN HEALTH (2014)
THE POTENTIAL VALUE OF ONGOING SUPPORT IN TYPE-1 DIABETES MELLITUS WITH DAFNEPLUS: EXPLORATORY PRE-TRIAL COST-EFFECTIVENESS ANALYSIS ON PROPOSED TRIAL END-POINT TARGET FOR 12-MONTH HBA1C IMPROVEMENT
H. Basarir et al.
VALUE IN HEALTH (2014)
Economic Costs of Diabetes in the U.S. in 2012
DIABETES CARE (2013)
The cost-effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model
J. Kruger et al.
DIABETIC MEDICINE (2013)
Computer Modeling of Diabetes and Its Complications: A Report on the Fifth Mount Hood Challenge Meeting
Andrew J. Palmer
VALUE IN HEALTH (2013)
A health economic analysis of clinical islet transplantation
Jessica Beckwith et al.
CLINICAL TRANSPLANTATION (2012)
Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
David M. Eddy et al.
MEDICAL DECISION MAKING (2012)
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Tom L. Van Belle et al.
PHYSIOLOGICAL REVIEWS (2011)
The quality of three decision-analytic diabetes models: a systematic health economic assessment
Christian Becker et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2011)
Economic models in type 2 diabetes
Y. Yi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Estimating the Cost of Type 1 Diabetes in the US: A Propensity Score Matching Method
Betty Tao et al.
PLOS ONE (2010)
A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment
Jean-Eric Tarride et al.
PHARMACOECONOMICS (2010)
Requisite models for strategic commissioning: the example of type 1 diabetes
Mara Airoldi et al.
HEALTH CARE MANAGEMENT SCIENCE (2008)
Computer modeling of diabetes and its complications -: A report on the Fourth Mount Hood Challenge Meeting
Andrew J. Palmer et al.
DIABETES CARE (2007)
Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada
Daniel T. Grima et al.
PHARMACOECONOMICS (2007)
All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999
SS Soedamah-Muthu et al.
DIABETOLOGIA (2006)
Development and validation, of the economic assessment of glycemic control and long-term effects of diabetes (EAGLE) model
Elvira Mueller et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2006)
Natural history of type 1 diabetes
P Achenbach et al.
DIABETES (2005)
Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
E Selvin et al.
ANNALS OF INTERNAL MEDICINE (2004)
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making
AJ Palmer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Validation of the CORE diabetes model against epidemiological and clinical studies
AJ Palmer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Cost-effectiveness of flexible intensive insulin management to enable dietary freedom in people with Type 1 diabetes in the UK
A Shearer et al.
DIABETIC MEDICINE (2004)
Archimedes - A trial-validated model of diabetes
DM Eddy et al.
DIABETES CARE (2003)
Validation of the archimedes diabetes model
DM Eddy et al.
DIABETES CARE (2003)
The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes
P Scuffham et al.
DIABETIC MEDICINE (2003)
Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy
I Mühlhauser et al.
JOURNAL OF INTERNAL MEDICINE (2000)
The cost-effectiveness of different management strategies for Type I diabetes: a Swiss perspective
AJ Palmer et al.
DIABETOLOGIA (2000)
Share Paper
